US Stock MarketDetailed Quotes

PMN ProMIS Neurosciences

Watchlist
  • 0.640
  • -0.022-3.31%
Close Mar 21 16:00 ET
20.92MMarket Cap16.00P/E (TTM)

ProMIS Neurosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
27.63%21.57M
-18.31%1.02M
-24.79%2.53M
113.83%12.63M
113.83%12.63M
327.71%16.9M
-85.96%1.25M
-75.62%3.36M
-65.21%5.91M
-65.21%5.91M
-Cash and cash equivalents
27.68%21.54M
-18.83%992.46K
-25.06%2.5M
114.41%12.6M
114.41%12.6M
330.23%16.87M
-86.27%1.22M
-75.78%3.33M
-65.32%5.88M
-65.32%5.88M
-Short-term investments
1.68%32.36K
1.67%32.36K
3.93%32.36K
4.35%32.36K
4.35%32.36K
4.21%31.82K
-2.64%31.83K
-7.62%31.13K
-6.73%31.01K
-6.73%31.01K
Receivables
280.82%630.28K
56.22%72.26K
84.98%76.81K
9.79%78.64K
9.79%78.64K
172.61%165.51K
-18.02%46.25K
-58.81%41.52K
47.11%71.63K
47.11%71.63K
-Accrued interest receivable
58.77%130.28K
--72.26K
--76.81K
--58.15K
--58.15K
--82.06K
----
----
--0
--0
-Taxes receivable
----
----
----
-71.40%20.49K
-71.40%20.49K
37.45%83.45K
-18.02%46.25K
--41.52K
47.11%71.63K
47.11%71.63K
-Other receivables
--500K
----
----
----
----
----
----
----
----
----
Prepaid assets
198.15%2.3M
23.16%200.01K
72.08%918.63K
-23.10%707.85K
-23.10%707.85K
-11.67%770.74K
-83.60%162.4K
2.28%533.85K
34.52%920.43K
34.52%920.43K
Current deferred assets
--0
683.59%99.56K
--0
--195.63K
--195.63K
----
-92.82%12.71K
--464.47K
--0
--0
Other current assets
-39.68%12.99K
282.90%12.96K
303.36%23.53K
41.19%6.53K
41.19%6.53K
370.92%21.54K
123.58%3.39K
--5.83K
5.38%4.62K
5.38%4.62K
Total current assets
37.25%24.51M
-4.71%1.41M
-19.51%3.55M
97.28%13.62M
97.28%13.62M
233.22%17.86M
-85.44%1.48M
-69.42%4.41M
-61.03%6.9M
-61.03%6.9M
Non current assets
Net PPE
----
----
----
--0
--0
--0
--0
--0
-93.13%321
-93.13%321
Goodwill and other intangible assets
----
----
----
--0
--0
-17.07%18.02K
-23.26%18.84K
-26.22%19.67K
-24.54%20.84K
-24.54%20.84K
Total non current assets
--0
--0
--0
--0
--0
-19.97%18.02K
-31.06%18.84K
-37.90%19.67K
-34.46%21.16K
-34.46%21.16K
Total assets
37.11%24.51M
-5.91%1.41M
-19.87%3.55M
96.68%13.62M
96.68%13.62M
232.16%17.88M
-85.30%1.5M
-69.35%4.43M
-60.98%6.92M
-60.98%6.92M
Liabilities
Current liabilities
Payables
-81.28%1.58M
-74.69%2.02M
-79.91%1.4M
163.60%7.84M
163.60%7.84M
368.83%8.41M
796.73%7.96M
983.68%6.99M
627.51%2.98M
627.51%2.98M
-accounts payable
-81.28%1.58M
-74.69%2.02M
-79.91%1.4M
163.60%7.84M
163.60%7.84M
368.83%8.41M
796.73%7.96M
983.68%6.99M
627.51%2.98M
627.51%2.98M
Current accrued expenses
-26.23%1.06M
49.10%1.16M
-27.71%1.24M
-56.18%1.51M
-56.18%1.51M
10.19%1.44M
-21.32%775.85K
130.52%1.72M
560.97%3.44M
560.97%3.44M
Current liabilities
-73.25%2.64M
-63.70%3.17M
-69.61%2.65M
45.79%9.35M
45.79%9.35M
217.92%9.85M
366.31%8.74M
526.18%8.71M
590.26%6.41M
590.26%6.41M
Non current liabilities
Employee benefits
-65.73%340.09K
--465.49K
--716.97K
--422K
--422K
--992.35K
----
----
--0
--0
Derivative product liabilities
5,042.18%14.26M
-96.18%49.23K
-94.30%108.32K
-94.93%94.19K
-94.93%94.19K
-82.14%277.36K
-19.79%1.29M
-63.89%1.9M
-74.36%1.86M
-74.36%1.86M
Total non current liabilities
1,050.05%14.6M
-60.02%514.72K
-56.60%825.29K
-72.24%516.19K
-72.24%516.19K
-18.25%1.27M
-19.79%1.29M
-79.59%1.9M
-83.34%1.86M
-83.34%1.86M
Total liabilities
55.00%17.24M
-63.23%3.69M
-67.28%3.47M
19.26%9.87M
19.26%9.87M
139.07%11.12M
188.19%10.03M
-0.94%10.61M
-31.56%8.27M
-31.56%8.27M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-0.63%-90.45M
-13.94%-99.72M
-13.95%-97.1M
-16.46%-93.47M
-16.46%-93.47M
-23.15%-89.89M
-30.57%-87.52M
-23.54%-85.21M
-29.04%-80.25M
-29.04%-80.25M
Paid-in capital
1.12%98.09M
23.25%97.82M
23.12%97.55M
23.37%97.59M
23.37%97.59M
31.12%97.01M
7.43%79.37M
918.19%79.23M
16.26%79.1M
16.26%79.1M
Gains losses not affecting retained earnings
0.00%-371.18K
0.00%-371.18K
-85.85%-371.18K
-89.99%-371.18K
-89.99%-371.18K
-37.31%-371.18K
-168.12%-371.19K
---199.72K
-3.96%-195.37K
-3.96%-195.37K
Total stockholders'equity
7.67%7.27M
73.30%-2.28M
101.25%77.1K
378.48%3.75M
378.48%3.75M
825.63%6.75M
-227.10%-8.53M
-265.25%-6.18M
-123.81%-1.35M
-123.81%-1.35M
Total equity
7.67%7.27M
73.30%-2.28M
101.25%77.1K
378.48%3.75M
378.48%3.75M
825.63%6.75M
-227.10%-8.53M
-265.25%-6.18M
-123.81%-1.35M
-123.81%-1.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 27.63%21.57M-18.31%1.02M-24.79%2.53M113.83%12.63M113.83%12.63M327.71%16.9M-85.96%1.25M-75.62%3.36M-65.21%5.91M-65.21%5.91M
-Cash and cash equivalents 27.68%21.54M-18.83%992.46K-25.06%2.5M114.41%12.6M114.41%12.6M330.23%16.87M-86.27%1.22M-75.78%3.33M-65.32%5.88M-65.32%5.88M
-Short-term investments 1.68%32.36K1.67%32.36K3.93%32.36K4.35%32.36K4.35%32.36K4.21%31.82K-2.64%31.83K-7.62%31.13K-6.73%31.01K-6.73%31.01K
Receivables 280.82%630.28K56.22%72.26K84.98%76.81K9.79%78.64K9.79%78.64K172.61%165.51K-18.02%46.25K-58.81%41.52K47.11%71.63K47.11%71.63K
-Accrued interest receivable 58.77%130.28K--72.26K--76.81K--58.15K--58.15K--82.06K----------0--0
-Taxes receivable -------------71.40%20.49K-71.40%20.49K37.45%83.45K-18.02%46.25K--41.52K47.11%71.63K47.11%71.63K
-Other receivables --500K------------------------------------
Prepaid assets 198.15%2.3M23.16%200.01K72.08%918.63K-23.10%707.85K-23.10%707.85K-11.67%770.74K-83.60%162.4K2.28%533.85K34.52%920.43K34.52%920.43K
Current deferred assets --0683.59%99.56K--0--195.63K--195.63K-----92.82%12.71K--464.47K--0--0
Other current assets -39.68%12.99K282.90%12.96K303.36%23.53K41.19%6.53K41.19%6.53K370.92%21.54K123.58%3.39K--5.83K5.38%4.62K5.38%4.62K
Total current assets 37.25%24.51M-4.71%1.41M-19.51%3.55M97.28%13.62M97.28%13.62M233.22%17.86M-85.44%1.48M-69.42%4.41M-61.03%6.9M-61.03%6.9M
Non current assets
Net PPE --------------0--0--0--0--0-93.13%321-93.13%321
Goodwill and other intangible assets --------------0--0-17.07%18.02K-23.26%18.84K-26.22%19.67K-24.54%20.84K-24.54%20.84K
Total non current assets --0--0--0--0--0-19.97%18.02K-31.06%18.84K-37.90%19.67K-34.46%21.16K-34.46%21.16K
Total assets 37.11%24.51M-5.91%1.41M-19.87%3.55M96.68%13.62M96.68%13.62M232.16%17.88M-85.30%1.5M-69.35%4.43M-60.98%6.92M-60.98%6.92M
Liabilities
Current liabilities
Payables -81.28%1.58M-74.69%2.02M-79.91%1.4M163.60%7.84M163.60%7.84M368.83%8.41M796.73%7.96M983.68%6.99M627.51%2.98M627.51%2.98M
-accounts payable -81.28%1.58M-74.69%2.02M-79.91%1.4M163.60%7.84M163.60%7.84M368.83%8.41M796.73%7.96M983.68%6.99M627.51%2.98M627.51%2.98M
Current accrued expenses -26.23%1.06M49.10%1.16M-27.71%1.24M-56.18%1.51M-56.18%1.51M10.19%1.44M-21.32%775.85K130.52%1.72M560.97%3.44M560.97%3.44M
Current liabilities -73.25%2.64M-63.70%3.17M-69.61%2.65M45.79%9.35M45.79%9.35M217.92%9.85M366.31%8.74M526.18%8.71M590.26%6.41M590.26%6.41M
Non current liabilities
Employee benefits -65.73%340.09K--465.49K--716.97K--422K--422K--992.35K----------0--0
Derivative product liabilities 5,042.18%14.26M-96.18%49.23K-94.30%108.32K-94.93%94.19K-94.93%94.19K-82.14%277.36K-19.79%1.29M-63.89%1.9M-74.36%1.86M-74.36%1.86M
Total non current liabilities 1,050.05%14.6M-60.02%514.72K-56.60%825.29K-72.24%516.19K-72.24%516.19K-18.25%1.27M-19.79%1.29M-79.59%1.9M-83.34%1.86M-83.34%1.86M
Total liabilities 55.00%17.24M-63.23%3.69M-67.28%3.47M19.26%9.87M19.26%9.87M139.07%11.12M188.19%10.03M-0.94%10.61M-31.56%8.27M-31.56%8.27M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -0.63%-90.45M-13.94%-99.72M-13.95%-97.1M-16.46%-93.47M-16.46%-93.47M-23.15%-89.89M-30.57%-87.52M-23.54%-85.21M-29.04%-80.25M-29.04%-80.25M
Paid-in capital 1.12%98.09M23.25%97.82M23.12%97.55M23.37%97.59M23.37%97.59M31.12%97.01M7.43%79.37M918.19%79.23M16.26%79.1M16.26%79.1M
Gains losses not affecting retained earnings 0.00%-371.18K0.00%-371.18K-85.85%-371.18K-89.99%-371.18K-89.99%-371.18K-37.31%-371.18K-168.12%-371.19K---199.72K-3.96%-195.37K-3.96%-195.37K
Total stockholders'equity 7.67%7.27M73.30%-2.28M101.25%77.1K378.48%3.75M378.48%3.75M825.63%6.75M-227.10%-8.53M-265.25%-6.18M-123.81%-1.35M-123.81%-1.35M
Total equity 7.67%7.27M73.30%-2.28M101.25%77.1K378.48%3.75M378.48%3.75M825.63%6.75M-227.10%-8.53M-265.25%-6.18M-123.81%-1.35M-123.81%-1.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.